<DOC>
	<DOCNO>NCT01842217</DOCNO>
	<brief_summary>Validation [ 18F ] -FES image estrogen receptor brain The primary objective study determine [ 18F ] -FES Positron Emission Tomography ( PET ) use quantify estrogen receptor expression human brain .</brief_summary>
	<brief_title>Validation 18FFES Imaging Brain Estrogen Receptors</brief_title>
	<detailed_description>Estrogens primary female sex hormone play major role development maintenance secondary sexual function . In addition , estrogens play important role cardiovascular , musculoskeletal , immunological , bone development central nervous system process . Actions estrogens mediate group specialize receptor , know estrogen receptor . Estrogens find neuroprotective may thus protect development neurodegenerative disorder like Alzheimer 's disease , Parkinson 's disease multiple sclerosis . In addition , estrogen may also play important role psychiatric disorder , like depression . To improve understand action estrogen brain , important study expression estrogen receptor brain . Positron emission tomography ( PET ) suitable technique non-invasive imaging brain receptor . [ 18F ] FES PET tracer regularly use UMCG image estrogen receptor expression breast cancer patient , never use quantitative imaging brain estrogen receptor . Quantification expression brain receptor PET usually require arterial blood sample obtain plasma input function tracer . Arterial blood sample cause discomfort patient therefore obstacle especially longitudinal study . The aim study therefore investigate whether [ 18F ] FES PET image quantification estrogen receptor human brain feasible without arterial blood sampling , use reference tissue model ( SRTM ) image derive input function ( IDIF ) , discomfort associate arterial blood sampling avoid .</detailed_description>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Female Age &gt; 18 year For postmenopausal woman : least 1 year menopause For premenopausal woman : regular menstruation Signed write informed consent Use estrogen receptor ligands , tamoxifen fulvestrant History ERpositive malignancy breast cancer Use contraceptive drug ( pill , injection implant ) For postmenopausal woman : ( history ) estrogen replacement therapy Pregnancy History removal ovary and/or uterus Current systemic disease Major metabolic disease ( e.g . diabetes , hyper hypothyroidism ) Somatic , organic neurological disorder Recent participation scientific research study ( &lt; 1 year ) involve radiation Claustrophobia Presence material body magnetize , like : pacemaker , metallic implants/prostheses , metal fragment , shunt , artificial heart valve , vascular clip , fix hearing aid , tattoos contain metal , hair implant , artificial denture</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>18F-FES PET</keyword>
	<keyword>Nuclear Medicine</keyword>
	<keyword>Premenopausal</keyword>
	<keyword>Postmenopausal</keyword>
	<keyword>Estrogen receptor</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Depression</keyword>
	<keyword>Cognition</keyword>
</DOC>